A revolutionary cancer treatment called belantamab mafodotin is now being offered by the NHS in a global first. This "Trojan ...

England is set to become the first health system globally to offer the "Trojan horse" therapy, belantamab mafodotin (Blenrep), developed by GSK, for patients with multiple myeloma, following its ...